Inventor · disambiguated record
Fenghuang Zhan
Also filed as: ZHAN FENGHUANG
15 granted patents·14 pending applications·179 citations·filing 2002–2021
92Inventor score
Files withUNIV ARKANSAS8BIOVENTURES LLC5SHAUGHNESSY JOHN D4UNIV IOWA RES FOUND4SHAUGHNESSY JR JOHN D3
Top patents by PatentIndex Score
29 records- 0195US7308364B2Diagnosis of multiple myeloma on gene expression profilingUNIV ARKANSAS MED SCIENCES·Filed 2003·Granted Dec 11, 2007·112 cites·2 claims
- 0292US8843320B2Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JOHN D·Filed 2005·Granted Sep 23, 2014·14 cites·6 claims
- 0391US7935679B2Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myelomaUNIV ARKANSAS·Filed 2005·Granted May 3, 2011·11 cites·4 claims
- 0490US7741035B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2005·Granted Jun 22, 2010·9 cites·4 claims
- 0589US7983850B2Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2008·Granted Jul 19, 2011·6 cites·9 claims
- 0684US10052304B2Compositions and methods for cancer therapyUNIV IOWA RES FOUND·Filed 2016·Granted Aug 21, 2018·5 cites·16 claims
- 0784US7668659B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2002·Granted Feb 23, 2010·12 cites·4 claims
- 0882US8954283B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JR JOHN D·Filed 2009·Granted Feb 10, 2015·4 cites·4 claims
- 0981US9650677B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2013·Granted May 16, 2017·1 cites·7 claims
- 1078US7894992B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2003·Granted Feb 22, 2011·5 cites·4 claims
- 1173US2020270691A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 1268US10597729B2Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2017·Granted Mar 24, 2020·0 cites·8 claims
- 1368US2020291486A1Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 1463US2008234139A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 1562US10577656B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2017·Granted Mar 3, 2020·0 cites·17 claims
- 1662US9714451B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Jul 25, 2017·0 cites·4 claims
- 1762US9574238B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Feb 21, 2017·0 cites·13 claims
- 1859US2011319470A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2011·Application pending·0 cites
- 1957US2023293649A1Cst6, cells expressing cst6 and methods of useBIOVENTURES LLC·Filed 2021·Application pending·0 cites
- 2055US2022160679A1Compositions and methods for cancer therapyUNIV IOWA RES FOUND·Filed 2021·Application pending·0 cites
- 2154US2008280779A1Gene expression profiling based identification of genomic signatures of multiple myeloma and uses thereofSHAUGHNESSY JR JOHN D·Filed 2007·Application pending·0 cites
- 2254US2008274911A1Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereofBURINGTON BART E·Filed 2008·Application pending·0 cites
- 2352US2008187930A1Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereofSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 2451US2013109017A1Multiple myeloma prognosis and treatmentUNIV UTAH RES FOUND·Filed 2012·Application pending·0 cites
- 2543US11298338B2Compositions and methods for cancer therapyUNIV IOWA RES FOUND·Filed 2017·Granted Apr 12, 2022·0 cites·8 claims
- 2635US2010316629A1Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
- 2735US2020209247A1Methods for identifying myeloma tumor-initiating cells and targeted therapyUNIV IOWA RES FOUND·Filed 2018·Application pending·0 cites
- 2834US2012184494A1Multiple myeloma prognosis and treatmentZANGARI MAURIZIO·Filed 2011·Application pending·0 cites
- 2931US2012178089A1Materials and methods for the identification of drug-resistant cancers and treatment of sameZHAN FENGHUANG·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →